Development and external validation of a prediction model for the risk of relapse in psoriasis after discontinuation of biologics
Multivariate models using available clinical parameters can predict relapse risk in psoriasis patients after biologics discontinuation. Early individual identification of patients at risk of relapse, and screening of candidate cohorts for long-term treatment or dose reduction may benefit both patients and physicians.
Authors
- Xingwu Duan (ORCID: https://orcid.org/0000-0002-0251-6356)
- Yanping Bai (ORCID: https://orcid.org/0000-0001-7326-3248)
- Bailin Chen
- Shan Huang (ORCID: https://orcid.org/0000-0002-0735-2960)
- Yiming Qi
Institutions
- Beijing University of Chinese Medicine (CN)
- China-Japan Friendship Hospital (CN)
- Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2024-11-26
- DOI
- https://doi.org/10.3389/fmed.2024.1488096
- Citations
- 3
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.72